Doing our part when disaster hits
We are proud to play our small part - from helping our nonprofit partners across the affected regions in their response efforts, to ensuring patients could continue to access their medicine amid disaster.
Setting the record straight: Why we publish data both positive and negative
Sharing our trial results, regardless of whether they reflect positively or negatively on our medicines is the right thing to do.
Fast-tracking our response to pandemics
In the wake of global pandemics such as Ebola and Zika, there is consensus that the world needs to be better prepared.
Hunting for energy savings
You never know what you might find when you hunt for waste.
Creating bricks and benches out of medical waste
Instead of being incinerated, medical lab waste at our Upper Providence site is being upcycled into bricks and benches.
Evolving our graduated approach to intellectual property
In developing countries, millions of people have no access to even the most basic healthcare services, including safe and effective medicines.
Buyer beware: importing drugs comes with big risks
At first blush, importing medicines sounds great – a patient without insurance or facing a high deductible or co-pay may find the prices quite attractive. But importation carries major risks.
How doctors and insurers get information about medicines
How do doctors and insurers in the US get the info they need to make decisions about medicines for patients?
Helping to change the world
FORTUNE Magazine published its 2016 list of companies that are changing the world, and we are honored to be ranked #1.